News

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...
GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs.  But the drugs can leave some ...
There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...
Sally Love has always enjoyed a drink - but, like many, it was during the Covid pandemic that her alcohol intake began to ...
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
A recent study revealed that weight loss drugs, GLP-1s, including Ozempic and Zepbound, may help in treating several chronic ...
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes ...